This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Medical Practice  • Law and Medicine  • Radiologic Imaging  • Radiologic Imaging, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Mike Mitka

JAMA. 2009;302(14):1522.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Experts testified at a September 9 hearing before the House Subcommittee on Energy and the Environment on proposed legislation that is intended to promote production of molybdenum 99 (⁹⁹Mo) in the United States for medical uses. ⁹⁹Mo decays to form technetium 99m, the isotope used in about 14 million US nuclear medicine procedures each year.

A House bill proposes to boost US production of molybdenum 99, which decays to form technetium 99m, an isotope used in procedures such as this hepatic scintigraph. (Photo credit: Publiphoto/www.sciencesource.com)

The American Medical Isotopes Production Act of 2009 (HR 3276 [http://thomas.loc.gov]) would also amend the Atomic Energy Act to prohibit exportation of highly enriched uranium for medical isotope production 7 to 10 years after the date of enactment.

The hearing came as the world faced a critical shortage of medical isotopes due to unexpected shutdowns of the primary . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?